查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1322266

苯二氮平类API 市场 - 全球行业分析、规模、份额、增长、趋势和预测，2023-2031 年

Benzodiazepine APIs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 244 Pages | 商品交期: 2-10个工作天内

价格

苯二氮平类API 市场 - 报告范围

TMR 关于全球苯二氮平类API 市场的报告研究了过去以及当前的增长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球苯二氮平类二氮卓API 市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。该报告还提供了2023年至2031年全球苯二氮平类原料药市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领袖和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解苯二氮平类API 市场。

该报告深入研究了全球苯二氮平类原料药市场的竞争格局。全球苯二氮平类原料药市场的主要参与者已经确定，并且每一个参与者都根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球苯二氮平类API 市场参与者的属性。

目录

第一章：前言

第 2 章：假设和研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017 - 2031 年全球市场分析与预测

第 5 章：关键见解

  • 苯二氮平类应用概述
  • 中国和美国对苯二氮卓类药物的监管情景
  • 欧洲氯硝西泮的三大市场
  • COVID-19 大流行对行业的影响（价值炼和短期/中期/长期影响）

第 6 章：全球市场分析与预测：按产品分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按产品，2017 - 2031
    • 阿普唑仑
    • 溴西泮
    • 利眠宁
    • 氯巴占
    • 氯硝西泮
    • 氯氮平
    • 地西泮
    • 劳拉西泮
    • 咪达唑仑
    • 硝西泮
    • 奥沙西泮
    • 替马西泮
    • 其他的
  • 市场吸引力：按产品分类

第 7 章：全球市场分析与预测：按行动时间

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按行动时间，2017 - 2031
    • 短动作
    • 中间的
    • 长效
  • 市场吸引力：按行动时间

第 8 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户划分，2017 - 2031
    • 製药与生物技术行业
    • 首席营销官
    • 其他（研究所等）
  • 市场吸引力：按最终用户划分

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 拉美
    • 中东和非洲
  • 市场吸引力：按国家/地区划分

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（按公司层级和规模）
  • 市场份额分析：按公司划分（2022 年）
  • 公司简介
    • Sun Pharmaceutical Industries Ltd.
    • Merck KGaA
    • LGC GmbH (LGC Science Group Holdings Limited)
    • Nortec Quimica SA
    • Centaur Pharmaceuticals
    • Eisai Co., Ltd
    • Global Calcium PVT LTD
    • Delphis Pharma
    • Mylan NV (Viatris Inc.)
    • Taj Pharmaceuticals Ltd.
Product Code: TMRGL85671

Benzodiazepine APIs Market - Scope of Report

TMR's report on the global Benzodiazepine APIs Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Benzodiazepine APIs Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Benzodiazepine APIs Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Benzodiazepine APIs Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Benzodiazepine APIs Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Benzodiazepine APIs Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Benzodiazepine APIs Market.

The report delves into the competitive landscape of the global Benzodiazepine APIs Market. Key players operating in the global Benzodiazepine APIs Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Benzodiazepine APIs Market profiled in this report.

Key Questions Answered in Global Benzodiazepine APIs Market Report:

  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global Benzodiazepine APIs Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Benzodiazepine APIs Market - Research Objectives and Research Approach

The comprehensive report on the global Benzodiazepine APIs Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Benzodiazepine APIs Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Benzodiazepine APIs.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Benzodiazepine APIs Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Benzodiazepine APIs Market Analysis and Forecast, 2017 - 2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Benzodiazepine Application Overview
  • 5.2. Regulatory Scenario for Benzodiazepines in China and U.S.
  • 5.3. Top 3 Markets for Clonazepam in Europe
  • 5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term impact)

6. Global Benzodiazepine APIs Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017 - 2031
    • 6.3.1. Alprazolam
    • 6.3.2. Bromazepam
    • 6.3.3. Chlordiazepoxide
    • 6.3.4. Clobazam
    • 6.3.5. Clonazepam
    • 6.3.6. Clorazepate
    • 6.3.7. Diazepam
    • 6.3.8. Lorazepam
    • 6.3.9. Midazolam
    • 6.3.10. Nitrazepam
    • 6.3.11. Oxazepam
    • 6.3.12. Temazepam
    • 6.3.13. Others
  • 6.4. Market Attractiveness, by Product

7. Global Benzodiazepine APIs Market Analysis and Forecast, by Time of Action

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Time of Action, 2017 - 2031
    • 7.3.1. Short Acting
    • 7.3.2. Intermediate
    • 7.3.3. Long Acting
  • 7.4. Market Attractiveness, by Time of Action

8. Global Benzodiazepine APIs Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017 - 2031
    • 8.3.1. Pharmaceutical & Biotechnology Industries
    • 8.3.2. CMOs
    • 8.3.3. Others (Research Institutes, etc.)
  • 8.4. Market Attractiveness, by End-user

9. Global Benzodiazepine APIs Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness, by Country/Region

10. North America Benzodiazepine APIs Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017 - 2031
    • 10.2.1. Alprazolam
    • 10.2.2. Bromazepam
    • 10.2.3. Chlordiazepoxide
    • 10.2.4. Clobazam
    • 10.2.5. Clonazepam
    • 10.2.6. Clorazepate
    • 10.2.7. Diazepam
    • 10.2.8. Lorazepam
    • 10.2.9. Midazolam
    • 10.2.10. Nitrazepam
    • 10.2.11. Oxazepam
    • 10.2.12. Temazepam
    • 10.2.13. Others
  • 10.3. Market Value Forecast, by Time of Action, 2017 - 2031
    • 10.3.1. Short Acting
    • 10.3.2. Intermediate
    • 10.3.3. Long Acting
  • 10.4. Market Value Forecast, by End-user, 2017 - 2031
    • 10.4.1. Pharmaceutical & Biotechnology Industries
    • 10.4.2. CMOs
    • 10.4.3. Others (Research Institutes, etc.)
  • 10.5. Market Value Forecast, by Country, 2017 - 2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Time of Action
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Benzodiazepine APIs Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017 - 2031
    • 11.2.1. Alprazolam
    • 11.2.2. Bromazepam
    • 11.2.3. Chlordiazepoxide
    • 11.2.4. Clobazam
    • 11.2.5. Clonazepam
    • 11.2.6. Clorazepate
    • 11.2.7. Diazepam
    • 11.2.8. Lorazepam
    • 11.2.9. Midazolam
    • 11.2.10. Nitrazepam
    • 11.2.11. Oxazepam
    • 11.2.12. Temazepam
    • 11.2.13. Others
  • 11.3. Market Value Forecast, by Time of Action, 2017 - 2031
    • 11.3.1. Short Acting
    • 11.3.2. Intermediate
    • 11.3.3. Long Acting
  • 11.4. Market Value Forecast, by End-user, 2017 - 2031
    • 11.4.1. Pharmaceutical & Biotechnology Industries
    • 11.4.2. CMOs
    • 11.4.3. Others (Research Institutes, etc.)
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Time of Action
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Benzodiazepine APIs Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017 - 2031
    • 12.2.1. Alprazolam
    • 12.2.2. Bromazepam
    • 12.2.3. Chlordiazepoxide
    • 12.2.4. Clobazam
    • 12.2.5. Clonazepam
    • 12.2.6. Clorazepate
    • 12.2.7. Diazepam
    • 12.2.8. Lorazepam
    • 12.2.9. Midazolam
    • 12.2.10. Nitrazepam
    • 12.2.11. Oxazepam
    • 12.2.12. Temazepam
    • 12.2.13. Others
  • 12.3. Market Value Forecast, by Time of Action, 2017 - 2031
    • 12.3.1. Short Acting
    • 12.3.2. Intermediate
    • 12.3.3. Long Acting
  • 12.4. Market Value Forecast, by End-user, 2017 - 2031
    • 12.4.1. Pharmaceutical & Biotechnology Industries
    • 12.4.2. CMOs
    • 12.4.3. Others (Research Institutes, etc.)
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of APAC
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Time of Action
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Benzodiazepine APIs Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017 - 2031
    • 13.2.1. Alprazolam
    • 13.2.2. Bromazepam
    • 13.2.3. Chlordiazepoxide
    • 13.2.4. Clobazam
    • 13.2.5. Clonazepam
    • 13.2.6. Clorazepate
    • 13.2.7. Diazepam
    • 13.2.8. Lorazepam
    • 13.2.9. Midazolam
    • 13.2.10. Nitrazepam
    • 13.2.11. Oxazepam
    • 13.2.12. Temazepam
    • 13.2.13. Others
  • 13.3. Market Value Forecast, by Time of Action, 2017 - 2031
    • 13.3.1. Short Acting
    • 13.3.2. Intermediate
    • 13.3.3. Long Acting
  • 13.4. Market Value Forecast, by End-user, 2017 - 2031
    • 13.4.1. Pharmaceutical & Biotechnology Industries
    • 13.4.2. CMOs
    • 13.4.3. Others (Research Institutes, etc.)
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Time of Action
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Benzodiazepine APIs Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017 - 2031
    • 14.2.1. Alprazolam
    • 14.2.2. Bromazepam
    • 14.2.3. Chlordiazepoxide
    • 14.2.4. Clobazam
    • 14.2.5. Clonazepam
    • 14.2.6. Clorazepate
    • 14.2.7. Diazepam
    • 14.2.8. Lorazepam
    • 14.2.9. Midazolam
    • 14.2.10. Nitrazepam
    • 14.2.11. Oxazepam
    • 14.2.12. Temazepam
    • 14.2.13. Others
  • 14.3. Market Value Forecast, by Time of Action, 2017 - 2031
    • 14.3.1. Short Acting
    • 14.3.2. Intermediate
    • 14.3.3. Long Acting
  • 14.4. Market Value Forecast, by End-user, 2017 - 2031
    • 14.4.1. Pharmaceutical & Biotechnology Industries
    • 14.4.2. CMOs
    • 14.4.3. Others (Research Institutes, etc.)
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Time of Action
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Sun Pharmaceutical Industries Ltd.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Merck KGaA
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. LGC GmbH (LGC Science Group Holdings Limited)
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Nortec Quimica S.A.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Centaur Pharmaceuticals
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Eisai Co., Ltd
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Global Calcium PVT LTD
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Delphis Pharma
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Mylan N.V. (Viatris Inc.)
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Taj Pharmaceuticals Ltd.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 03: Global Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 06: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 07: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 08: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 09: U.S. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 10: U.S. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 11: U.S. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: Canada Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 13: Canada Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 14: Canada Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 16: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 17: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 18: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 19: Germany Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 20: Germany Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 21: Germany Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 22: U.K. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: U.K. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 24: U.K. Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: France Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 26: France Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 27: France Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 28: Italy Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 29: Italy Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 30: Italy Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Spain Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 32: Spain Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 33: Spain Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 34: Rest of Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 35: Rest of Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 36: Rest of Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 37: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 38: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 39: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 40: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017-2031
  • Table 41: Japan Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 42: Japan Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 43: Japan Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 44: China Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 45: China Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 46: China Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 47: India Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 48: India Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 49: India Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 50: Australia & New Zealand Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 51: Australia & New Zealand Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 52: Australia & New Zealand Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 53: Rest of Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 54: Rest of Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 55: Rest of Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 56: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 57: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 58: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 59: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 60: Brazil Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 61: Brazil Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 62: Brazil Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 63: Mexico Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 64: Mexico Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 65: Mexico Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 66: Rest of Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 67: Rest of Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 68: Rest of Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 69: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 70: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 71: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 72: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 73: GCC Countries Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 74: GCC Countries Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 75: GCC Countries Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 76: South Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 77: South Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 78: South Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 79: Rest of MEA Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 80: Rest of MEA Benzodiazepine APIs Market Value (US$ Mn) Forecast, by Time of Action, 2017-2031
  • Table 81: Rest of MEA Benzodiazepine APIs Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Benzodiazepine API Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Benzodiazepine APIs Market Attractiveness Analysis, by Product 2023-2031
  • Figure 03: Global Benzodiazepine APIs Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 04: Global Benzodiazepine APIs Market Value (US$ Mn), by Alprazolam, 2017-2031
  • Figure 05: Global Benzodiazepine APIs Market Value (US$ Mn), by Bromazepam, 2017-2031
  • Figure 06: Global Benzodiazepine APIs Market Value (US$ Mn), by Irreversible Chlordiazepoxide, 2017-2031
  • Figure 07: Global Benzodiazepine APIs Market Value (US$ Mn), by Clobazam, 2017-2031
  • Figure 08: Global Benzodiazepine APIs Market Value (US$ Mn), by Clonazepam, 2017-2031
  • Figure 09: Global Benzodiazepine APIs Market Value (US$ Mn), by Clorazepate, 2017-2031
  • Figure 10: Global Benzodiazepine APIs Market Value (US$ Mn), by Diazepam, 2017-2031
  • Figure 11: Global Benzodiazepine APIs Market Value (US$ Mn), by Lorazepam, 2017-2031
  • Figure 12: Global Benzodiazepine APIs Market Value (US$ Mn), by Midazolam, 2017-2031
  • Figure 13: Global Benzodiazepine APIs Market Value (US$ Mn), by Nitrazepam, 2017-2031
  • Figure 14: Global Benzodiazepine APIs Market Value (US$ Mn), by Oxazepam, 2017-2031
  • Figure 15: Global Benzodiazepine APIs Market Value (US$ Mn), by Temazepam, 2017-2031
  • Figure 16: Global Benzodiazepine APIs Market Value (US$ Mn), by Others, 2017-2031
  • Figure 17: Global Benzodiazepine APIs Market Value Share Analysis, by Time of Action, 2022 and 2031
  • Figure 18: Global Benzodiazepine APIs Market Attractiveness Analysis, Time of Action, 2023-2031
  • Figure 19: Global Benzodiazepine APIs Market Revenue (US$ Mn), by Short Acting, 2017-2031
  • Figure 20: Global Benzodiazepine APIs Market Revenue (US$ Mn), by Intermediate, 2017-2031
  • Figure 21: Global Benzodiazepine APIs Market Revenue (US$ Mn), by Long Acting, 2017-2031
  • Figure 22: Global Benzodiazepine APIs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 23: Global Benzodiazepine APIs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 24 Global Benzodiazepine APIs Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Industries, 2017-2031
  • Figure 25: Global Benzodiazepine APIs Market Revenue (US$ Mn), by CMOs, 2017-2031
  • Figure 26: Global Benzodiazepine APIs Market Revenue (US$ Mn), Others, 2017-2031
  • Figure 27: Global Benzodiazepine APIs Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 28: Global Benzodiazepine APIs Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 29: North America Benzodiazepine APIs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 30: North America Benzodiazepine APIs Market Attractiveness Analysis, by Product, 2022 and 2031
  • Figure 31: North America Benzodiazepine APIs Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 32: North America Benzodiazepine APIs Market Value Share Analysis, by Time of Action, 2022 and 2031
  • Figure 33: North America Benzodiazepine APIs Market Attractiveness Analysis, Time of Action, 2023-2031
  • Figure 34: North America Benzodiazepine APIs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 35: North America Benzodiazepine APIs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 36: North America Benzodiazepine APIs Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 37: North America Benzodiazepine APIs Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 38: Europe Benzodiazepine APIs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 39: Europe Benzodiazepine APIs Market Attractiveness Analysis, by Product 2023-2031
  • Figure 40: Europe Benzodiazepine APIs Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 41: Europe Benzodiazepine APIs Market Value Share Analysis, by Time of Action, 2022 and 2031
  • Figure 42: Europe Benzodiazepine APIs Market Attractiveness Analysis, Time of Action, 2023-2031
  • Figure 43: Europe Benzodiazepine APIs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 44: Europe Benzodiazepine APIs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 45: Europe Benzodiazepine APIs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 46: Europe Benzodiazepine APIs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Asia Pacific Benzodiazepine APIs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 48: Asia Pacific Benzodiazepine APIs Market Attractiveness Analysis, by Product 2023-2031
  • Figure 49: Asia Pacific Benzodiazepine APIs Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 50: Asia Pacific Benzodiazepine APIs Market Value Share Analysis, by Time of Action, 2022 and 2031
  • Figure 51: Asia Pacific Benzodiazepine APIs Market Attractiveness Analysis, Time of Action, 2023-2031
  • Figure 52: Asia Pacific Benzodiazepine APIs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 53: Asia Pacific Benzodiazepine APIs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 54: Asia Pacific Benzodiazepine APIs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Asia Pacific Benzodiazepine APIs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Latin America Benzodiazepine APIs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 57: Latin America Benzodiazepine APIs Market Attractiveness Analysis, by Product 2023-2031
  • Figure 58: Latin America Benzodiazepine APIs Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 59: Latin America Benzodiazepine APIs Market Value Share Analysis, by Time of Action, 2022 and 2031
  • Figure 60: Latin America Benzodiazepine APIs Market Attractiveness Analysis, Time of Action, 2023-2031
  • Figure 61: Latin America Benzodiazepine APIs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 62: Latin America Benzodiazepine APIs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 63: Latin America Benzodiazepine APIs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 64: Latin America Benzodiazepine APIs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 65: Middle East & Africa Benzodiazepine APIs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 66: Middle East & Africa Benzodiazepine APIs Market Attractiveness Analysis, by Product 2023-2031
  • Figure 67: Middle East & Africa Benzodiazepine APIs Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 68: Middle East & Africa Benzodiazepine APIs Market Value Share Analysis, by Time of Action, 2022 and 2031
  • Figure 69: Middle East & Africa Benzodiazepine APIs Market Attractiveness Analysis, Time of Action, 2023-2031
  • Figure 70: Middle East & Africa Benzodiazepine APIs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 71: Middle East & Africa Benzodiazepine APIs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 72: Middle East & Africa Benzodiazepine APIs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 73: Middle East & Africa Benzodiazepine APIs Market Attractiveness Analysis, by Country/Sub-region , 2023-2031